Company news
Wuhan Keqian Biology Co. Ltd. Class A (SSE:688526) news
Wuhan Keqian Biology Co. Ltd. Class A news releases on 6ix. Latest, Sep 22, 2026: "Wuhan Keqian Biology Co., Ltd."Indicative Announcement on Expiration…
Press releases & updates
"Wuhan Keqian Biology Co., Ltd."Indicative Announcement on Expiration and Termination of the Shareholders' Concerted Action Agreement and the Company Having No Actual Controller
September 21, 2026
"Wuhan Keqian Biology Co., Ltd."Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
September 11, 2026
"Wuhan Keqian Biology Co., Ltd."Announcement on the 2026 Semi-annual Performance Briefing
August 31, 2026
"Wuhan Keqian Biology Co., Ltd."Announcement on Expiration of the Lock-up Period and Satisfaction of Certain Unlocking Conditions under the 2025 Employee Stock Ownership Plan
August 26, 2026
"Wuhan Keqian Biology Co., Ltd."Voluntary Disclosure Announcement on the Proposed Signing of a Cooperative R&D Agreement with Huazhong Agricultural University and the Related Party Transaction
August 11, 2026
"Wuhan Keqian Biology Co., Ltd."Announcement on Voluntary Disclosure of Obtaining New Veterinary Drug Registration Certificate
July 30, 2026
"Wuhan Keqian Biology Co., Ltd."Announcement on Voluntary Disclosure of Planned Signing of Cooperative R&D Agreements with Huazhong Agricultural University and Liaoning Animal Disease Prevention and Control Center and Related Party Transactions
July 14, 2026
"Wuhan Keqian Biology Co.,Ltd"Announcement on Attending the 2026 Collective Reception Day for Investors of Listed Companies in Hubei Jurisdiction and 2025 Annual Performance Briefing
July 1, 2026
Announcement on Implementation of Dividend Distribution for 2025
May 19, 2026
Announcement on 2025 Annual and Q1 2026 Performance and Cash Dividend Briefing
April 30, 2026
Report for Q1 2026
April 29, 2026
Announcement on Resolutions of the 2025 Annual General Meeting
April 28, 2026
Announcement on the Remuneration Plan for Directors and Senior Management Members in 2026
April 7, 2026
Announcement on Voluntary Disclosure of Proposing to Sign a Cooperative Research and Development Agreement with Huazhong Agricultural University and Related Party Transactions
March 24, 2026
Announcement on Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Voluntary Disclosure of Obtaining Approval of New Veterinary Drug Registration Certificate
February 9, 2026
Announcement on Resignation of Non-independent Director and Election of Employee Representative Director
November 28, 2025
Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
November 14, 2025
Announcement on Convening the Q3 2025 Performance Briefing
November 3, 2025
Announcement on Cancellation of the Board of Supervisors, Amendments to the "Articles of Association", and the Revision and Formulation of Internal Corporate Governance Systems
October 29, 2025
Announcement on Cancellation of Account for Partial Raised Funds
September 23, 2025
Announcement on Increasing the Amount of Idle Self-owned Funds Used for Cash Management
September 22, 2025
Announcement on Actual Controller Renewing the Agreement of Persons Acting in Concert
September 19, 2025
Announcement on Attending Semi-annual Collective Performance Briefing for Biological Products and CXO Industry on SSE STAR Market 2025
September 1, 2025
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2025
August 25, 2025
Announcement on Resolutions of the 1st Holders' Meeting for 2025 Employee Stock Ownership Plan
August 12, 2025
Announcement on Resolutions of the 11th Meeting of the 4th Board of Supervisors
July 9, 2025
Announcement on Resolution of the 2nd Extraordinary General Meeting in 2025
June 26, 2025
Announcement on Resolution of the 10th Meeting of the 4th Board of Supervisors
June 10, 2025
Announcement on Implementation of Dividend Distribution for 2024
June 9, 2025
Announcement on Resolution of the 2024 Annual General Meeting
May 19, 2025
Announcement on 2024 Annual and Q1 2025 Performance and Cash Dividend Briefing
May 6, 2025
Announcement on 2024 Annual Profit Distribution Plan
April 28, 2025
2025 Employee Stock Ownership Plan
April 11, 2025
Announcement on Resolutions of the 1st Congress of Workers in 2025
March 24, 2025
Preliminary Earnings Estimate for 2024
February 26, 2025
Announcement on Implementation Results of Share Repurchase and Share Changes
February 20, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
February 5, 2025
Announcement on Voluntary Disclosure of Obtaining Veterinary Drug GMP Certificate and Veterinary Drug Production License
December 31, 2024
Announcement on Resolutions of the 6th Meeting of the 4th Board of Supervisors
December 9, 2024
Announcement on Convening the Q3 2024 Performance Briefing
October 30, 2024
Announcement on Abnormal Fluctuations in Stock Trading
October 9, 2024
Announcement on the Result of Shareholding Reduction by the Shareholder and Supervisor with Over 5% Shares
October 8, 2024
Announcement on Renewal of Concerted Action Agreement by Actual Controller
September 20, 2024
Announcement on Convening the 2024 Semi-annual Performance Briefing
September 19, 2024
2024 Semi-annual Report
August 29, 2024
Announcement on Resolutions of the 3rd Meeting of the 4th Board of Supervisors
August 23, 2024
Announcement on the Implementation of Repurchase and Cancellation of Partial Category I Restricted Stocks under the 2021 Restricted Stock Incentive Plan
July 22, 2024